Exhibit 99.1
 | Notification of cessation of +securities |
Entity name
ALTERITY THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Wednesday January 05, 2022
Details of +securities that have ceased
| | ASX +security
code | | Security description | | Number of
+securities that
have ceased | | The +securities have
ceased due to | | Date of
cessation |
| | | | | | | | | | |
| | ATHAAB | | OPTION EXPIRING 17-SEP-2025 EX $0.09 | | 14,000,000 | | Lapse of conditional right to 04/01/2022 securities because the conditions have not been, or have become incapable of being, satisfied | | 04/01/2022 |
Refer to next page for full details of the announcement
| Notification of cessation of +securities | 1 / 4 | |
| Notification of cessation of +securities |
| Part 1 - Announcement Details | |
| | |
1.1 Name of +Entity
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) provide the following information about our issued capital.
| 1.2 Registered Number Type | | Registration Number |
| | | |
| ABN | | 37080699065 |
1.3 ASX issuer code
ATH
1.4 The announcement is
þ New announcement
1.5 Date of this announcement
5/1/2022
| Notification of cessation of +securities | 2 / 4 | |
| Notification of cessation of +securities |
| Part 2 - Details of +equity securities or +debt securities that have ceased | |
| | |
ASX +Security Code and Description
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09
Unquoted +equity securities that have ceased
Number of securities that have ceased
14,000,000
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied
| | Date of cessation | Is the entity paying any consideration for the cessation? |
| | 4/1/2022 | þ No |
Any other information the entity wishes to notify to ASX about the cessation?
| Notification of cessation of +securities | 3 / 4 | |
| Notification of cessation of +securities |
| Part 3 - Issued capital following changes | |
| | |
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
| | ASX +security code and description | | Total number of +securities on issue |
| | | | |
| | ATH : ORDINARY FULLY PAID | | 2,406,874,578 |
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
| | ASX +security code and description | Total number of +securities on issue |
| | | |
| | ATHAI : OPTION EXPIRING 31-JAN-2023 EX $0.083 | 700,000 |
| | ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | 35,000,000 |
| | ATHAS : OPTION EXPIRING 06-JUN-2022 EX 7C | 7,000,000 |
| | ATHAAA : OPTION EXPIRING 14-DEC-2022 EX 11C | 12,450,000 |
| | ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07 | 674,694,939 |
| | ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | 91,392,720 |
Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.
| Notification of cessation of +securities | 4 / 4 | |
